Oak Associates LTD Vertex Pharmaceuticals Inc Transaction History

Oak Associates LTD

$1.51 Billion
Q2 2024

A detailed history of Oak Associates LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Oak Associates LTD holds 4,759 shares of VRTX stock, worth $2.39 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

4,759

Previous 4,859 2.06%

Holding current value

$2.39 Million

Previous $2.03 Million 9.8%

% of portfolio

0.15%

Previous 0.14%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$392.81 - $485.53 $39,281 - $48,553	-100 Reduced 2.06%	4,759 $2.23 Million
Q1 2024 May 10, 2024	SELL	$407.69 - $446.08 $814,564 - $891,267	-1,998 Reduced 29.14%	4,859 $2.03 Million
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $122,451 - $146,612	-357 Reduced 4.95%	6,857 $2.79 Million
Q3 2023 Nov 13, 2023	SELL	$338.18 - $362.46 $74,399 - $79,741	-220 Reduced 2.96%	7,214 $2.51 Million
Q2 2023 Aug 11, 2023	SELL	$314.42 - $351.91 $182,992 - $204,811	-582 Reduced 7.26%	7,434 $2.62 Million
Q1 2023 May 11, 2023	BUY	$283.23 - $323.1 $308,154 - $351,532	1,088 Added 15.7%	8,016 $2.53 Million
Q4 2022 Feb 09, 2023	BUY	$285.76 - $321.48 $200,032 - $225,036	700 Added 11.24%	6,928 $2 Million
Q1 2022 May 12, 2022	SELL	$221.42 - $260.97 $39,412 - $46,452	-178 Reduced 2.78%	6,228 $1.63 Million
Q4 2021 Feb 10, 2022	SELL	$177.01 - $223.45 $88,505 - $111,725	-500 Reduced 7.24%	6,406 $1.41 Million
Q2 2021 Aug 09, 2021	SELL	$187.49 - $221.1 $54,559 - $64,340	-291 Reduced 4.04%	6,906 $1.39 Million
Q1 2021 May 13, 2021	BUY	$207.02 - $241.31 $30,431 - $35,472	147 Added 2.09%	7,197 $1.55 Million
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $2.5 Million - $3.34 Million	-12,090 Reduced 63.17%	7,050 $1.67 Million
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $15,339 - $18,186	60 Added 0.31%	19,140 $5.21 Million
Q2 2020 Aug 11, 2020	BUY	$225.48 - $295.8 $4.3 Million - $5.64 Million	19,080 New	19,080 $5.54 Million

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Associates LTD , based on Form 13F filings with the SEC.

News

Stay updated on Oak Associates LTD with notifications on news.

Account

Oak Associates LTD Vertex Pharmaceuticals Inc Transaction History